Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Within-subject comparison of three intravenous diuretic regimens in ambulatory day-hospital patients with chronic heart failure and volume overload
MOH_2023-04-01_012490Phase 4Active, not recruiting
- Sponsor
- ד"ר אהרן (רוני) עבו
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide, metolazone and acetazolamide in chronic heart failure (CHF) (3 arms), sponsored by ד"ר אהרן (רוני) עבו. Started Mar 2023; status: active, not recruiting.
02
Drugs
furosemidemetolazoneacetazolamide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on MOH_2023-04-01_012490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-04-01_012490.